Tang Xing, Tian XiaoLin, Ci Lei
School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, PR China.
Drug Dev Ind Pharm. 2004;30(10):1079-87. doi: 10.1081/ddc-200040286.
This paper is designed to investigate a novel sustained release system for Traditional Chinese Medicinal Compound Recipe (TCMCR) by incorporating three kinds of pH-dependent gradient-release coated pellets into capsules. In our study, dosage reform was conducted on the TCMCR model drug--Guanxin Suhe Wan (GSW), which is in the traditional form of honey bolus, comprising Styrax, Borneolumsyntheticum, Olbanum, Radix aristolochiae and Lignum santali albi. In this study, the beta-CD inclusion complexes were prepared separately for Styrax, Borneolumsyntheticum and the volatile oil extracted from the mixture of Olbanum, Radix aristolochiae and Lignum santali albi. Pellets were prepared in a centrifugal granulator using the powder layering technique and then divided into 3 equal weight portions and coated with HPMC, HPMCP HP-55 and Eudragit L100/S100 to obtain gradient release in stomach, duodenum and jejunum or ileum respectively. On this basis, a pH-dependent sustained-release pellets system, "Guanxin Suhe Sustained-release Capsules"(GSSC), was prepared by mixing the above three kinds of coated pellets at the weight ratio of 1:1:1. Pharmacokinetic (PK) studies between GSW and GSSC were made on male volunteers and isolated guinea pig hearts by plasma drug concentration method and serum pharmacology method respectively. In plasma drug concentration method, Tmax was 0.42 h and 1.08 h for GSW and GSSC respectively, while in the serum pharmacology method, Tmax was 0.56 h and 0.52 h respectively. The relative bioavailability of GSSC to GSW was 95.62% and 121.82% separately in the above two methods, indicating a similarity between the two methods in predicting the PK behavior of GSSC.
本文旨在通过将三种pH依赖型梯度释放包衣微丸装入胶囊来研究一种新型的中药复方缓释系统。在我们的研究中,对中药复方模型药物——冠心苏合丸(GSW)进行了剂型改革,其传统剂型为蜜丸,由苏合香、冰片、乳香、广木香和檀香组成。在本研究中,分别制备了苏合香、冰片以及从乳香、广木香和檀香混合物中提取的挥发油的β-环糊精包合物。采用离心造粒机通过粉末层积技术制备微丸,然后将其等分为3份,分别用羟丙甲纤维素(HPMC)、羟丙甲纤维素邻苯二甲酸酯HP-55和丙烯酸树脂L100/S100包衣,以分别在胃、十二指肠和空肠或回肠实现梯度释放。在此基础上,按1:1:1的重量比将上述三种包衣微丸混合,制备了pH依赖型缓释微丸系统“冠心苏合缓释胶囊”(GSSC)。分别采用血浆药物浓度法和血清药理学方法,在雄性志愿者和离体豚鼠心脏上对GSW和GSSC进行了药代动力学(PK)研究。在血浆药物浓度法中,GSW和GSSC的达峰时间(Tmax)分别为0.42小时和1.08小时;而在血清药理学方法中,Tmax分别为0.56小时和0.52小时。在上述两种方法中,GSSC相对于GSW的相对生物利用度分别为95.62%和121.82%,表明两种方法在预测GSSC的PK行为方面具有相似性。